Clinical Trials on 非酒精性脂肪性肝炎 in United States
总计9273个结果
-
Jeffrey BrowningNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的
-
Zydus Therapeutics Inc.完全的
-
Case Western Reserve UniversityAmerican College of Gastroenterology完全的
-
Keith D Lindor, M.D.Ajinomoto USA, INC.完全的
-
Medical College of WisconsinENDRA Life Sciences, Inc.招聘中
-
University of MichiganAmerican Association for the Study of Liver Diseases完全的
-
University of California, San DiegoDaiichi Sankyo, Inc.完全的
-
Milton S. Hershey Medical Center招聘中
-
Corcept Therapeutics招聘中
-
CytoDyn, Inc.Amarex Clinical Research完全的
-
Naga P. ChalasaniDSM Nutritional Products, Inc.完全的非酒精性脂肪肝 | 非酒精性脂肪性肝炎 | 非酒精性脂肪肝美国
-
89bio, Inc.完全的
-
MedImmune LLC完全的
-
Cascade Pharmaceuticals, IncLaboratory Corporation of America完全的
-
Galmed Research and Development, Ltd.Medical University of Graz; Tel-Aviv Sourasky Medical Center; Fondazione IRCCS Ca' Granda, Ospedale... 和其他合作者完全的肝病 | 脂肪肝 | 非酒精性脂肪性肝炎 | 肝纤维化美国, 智利, 以色列, 意大利, 法国, 德国, 墨西哥, 乔治亚州, 立陶宛, 香港, 罗马尼亚
-
Oasis Pharmaceuticals, LLCMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)招聘中
-
Corcept Therapeutics终止
-
Manchester University NHS Foundation TrustUniversity of Nottingham; University of Manchester; Innovate UK招聘中
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty Ltd完全的
-
Conatus Pharmaceuticals Inc.完全的
-
University of Wisconsin, MadisonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); GE Healthcare; Pfizer; Siemens Medical Solutions 和其他合作者主动,不招人
-
Virginia Commonwealth UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)招聘中
-
Alnylam Pharmaceuticals终止
-
Terns, Inc.完全的
-
AstraZenecaParexel完全的